What is the interaction between fluvoxamine (selective serotonin reuptake inhibitor) and propranolol (non‑selective beta‑blocker), and how should the propranolol dose be adjusted?

Fluvoxamine and Propranolol Interaction

When combining fluvoxamine with propranolol, reduce the initial propranolol dose by at least 50-80% and titrate cautiously, as fluvoxamine causes a 2- to 5-fold increase in propranolol plasma concentrations, significantly increasing the risk of bradycardia, hypotension, and cardiovascular adverse events.

Mechanism of Interaction

Fluvoxamine is a potent inhibitor of multiple cytochrome P450 enzymes, particularly CYP1A2, and also inhibits CYP2D6, CYP2C19, CYP2C9, and CYP3A4 1. Propranolol is extensively metabolized through hepatic oxidation, making it highly susceptible to drug interactions with CYP450 inhibitors 2.

The FDA drug label explicitly warns that co-administration of fluvoxamine 100 mg/day with propranolol 160 mg/day resulted in a mean 5-fold increase (range 2-17 fold) in minimum propranolol plasma concentrations 2. This dramatic elevation in propranolol levels leads to:

• Enhanced reduction in heart rate
• Potentiated reduction in exercise diastolic blood pressure
• Risk of bradycardia and hypotension
• Documented cases of orthostatic hypotension 2

Clinical Management Algorithm

Starting Propranolol in Patients Already on Fluvoxamine:

1. Reduce the standard propranolol starting dose by 50-80%

   • If typical starting dose is 40 mg twice daily, begin with 10-20 mg twice daily
   • For propranolol LA formulations, reduce proportionally

2. Monitor cardiovascular parameters closely:

   • Check heart rate and blood pressure before each dose increase
   • Monitor for symptoms of excessive beta-blockade (fatigue, dizziness, cold extremities)
   • Observe for orthostatic hypotension

3. Titrate extremely cautiously:

   • Increase dose by no more than 10-20 mg every 1-2 weeks
   • Reassess cardiovascular parameters with each adjustment
   • Maximum doses will likely be substantially lower than standard propranolol dosing

Adding Fluvoxamine to Existing Propranolol Therapy:

1. Reduce propranolol dose by 50% when initiating fluvoxamine

   • This preemptive reduction prevents accumulation as fluvoxamine reaches steady-state (5-10 days) 3, 4

2. Monitor intensively during the first 2 weeks:

   • Daily heart rate and blood pressure checks for the first week
   • Watch for bradycardia (HR <60 bpm or <1st percentile for age in children)
   • Assess for hypotension using age-appropriate criteria

3. Adjust propranolol dose based on clinical response:

   • Further reduce if bradycardia or hypotension develops
   • May require propranolol doses 20-50% of the original dose

Critical Warnings and Pitfalls

The interaction is clinically significant and potentially dangerous 5. A 2020 study demonstrated that patients receiving antidepressants with moderate-to-strong CYP2D6 inhibitory potential (including fluvoxamine analogs) combined with beta-blockers had a 53% increased risk of hospitalization or emergency department visits for hemodynamic events (HR 1.53,95% CI 1.03-2.81) 5.

Common Pitfalls to Avoid:

• Do not use standard propranolol dosing when combined with fluvoxamine—this will result in excessive beta-blockade
• Do not assume the interaction is minor—the 5-fold increase in propranolol levels is substantial and clinically relevant 2
• Avoid abrupt propranolol discontinuation if separating the medications, as this can cause rebound hypertension and tachycardia 6, 7
• Do not overlook metoprolol—the FDA label specifically mentions cases of bradycardia and hypotension with fluvoxamine-metoprolol combinations 2

Special Populations:

Elderly patients are at particularly high risk for adverse cardiovascular events from this interaction 5. Use even more conservative dose reductions (consider 80% reduction in propranolol dose).

Patients with hepatic impairment have 30% decreased fluvoxamine clearance 2, potentially magnifying the interaction—use extreme caution and lower doses of both medications.

Alternative Beta-Blockers

Atenolol is a safer alternative when beta-blockade is needed in patients on fluvoxamine. Co-administration of fluvoxamine 100 mg/day with atenolol 100 mg/day did not affect atenolol plasma concentrations 2. Atenolol is eliminated primarily by renal excretion rather than hepatic metabolism, avoiding the CYP450-mediated interaction 2.

Monitoring Parameters

• Heart rate: Check before each dose adjustment; hold propranolol if HR <60 bpm (adults) or below age-appropriate norms (children)
• Blood pressure: Monitor for hypotension, particularly orthostatic changes
• Clinical symptoms: Assess for dizziness, fatigue, syncope, cold extremities, or worsening heart failure symptoms
• Consider propranolol dose reduction if any signs of excessive beta-blockade develop

The combination requires careful dose adjustment and close monitoring but can be used safely with appropriate precautions 2.